cancer-drug approvals
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
cancer-drug approvals
Jul 23, 2024, 15:52 |
Drugs
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
In the rapidly evolving field of oncology, we are witnessing remarkable advancements in various treatment…
May 3, 2024, 05:06 |
Opinion
Vincent Rajkumar on the Importance of Accelerated Approval for Cancer Treatment
Vincent Rajkumar, Editor in Chief of Blood Cancer Journal, shared on X: "On Accelerated Approval…
Mar 15, 2024, 18:14 |
Blog
Vivek Subbiah: 'Tissue-Agnostic Cancer Therapy Approvals' now published as a book chapter in 'Precision Oncology and Cancer Surgery'
Vivek Subbiah shared a post on LinkedIn: "Guess what arrived in my office today hot…
Dec 10, 2023, 18:07 |
Blog
Nathan Vardi: I traveled down to Maryland and spent the day at the FDA
Nathan Vardi, Managing Editor, Enterprise at MarketWatch, shared on LinkedIn: "Not long after my book, FOR…
All:
4
Posts:
1 - 100
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Our commitment to seek all possible pathways to make BOT/BAL available to patients is unwavering: Steven O'Day, Agenus CMO
Facebook
RSS Feed
Twitter
Linkedin
Youtube